Kobayashi, Miwako;
Pilishvili, Tamara;
Farrar, Jennifer L;
Leidner, Andrew J;
Gierke, Ryan;
Prasad, Namrata;
Moro, Pedro;
Campos-Outcalt, Doug;
Morgan, Rebecca L;
Long, Sarah S;
Poehling, Katherine A;
Cohen, Adam L.
his report compiles and summarizes all published recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults aged ≥19 years in the United States. This report also includes updated and new clinical guidance for implementation from CDC.
Bef...
Nanchal, Rahul;
Subramanian, Ram;
Alhazzani, Waleed;
Dionne, Joanna C;
Peppard, William J;
Singbartl, Kai;
Truwit, Jonathon;
Al-Khafaji, Ali H;
Killian, Alley J;
Alquraini, Mustafa;
Alshammari, Khalil;
Alshamsi, Fayez;
Belley-Cote, Emilie;
Cartin-Ceba, Rodrigo;
Hollenberg, Steven M;
Galusca, Dragos M;
Huang, David T;
Hyzy, Robert C;
Junek, Mats;
Kandiah, Prem;
Kumar, Gagan;
Morgan, Rebecca L;
Morris, Peter E;
Olson, Jody C;
Sieracki, Rita;
Steadman, Randolph;
Taylor, Beth;
Karvellas, Constantine J.
To develop evidence-based recommendations for clinicians caring for adults with acute liver failure (ALF) or acute on chronic liver failure (ACLF) in the ICU. The guideline panel comprised 27 members with expertise in aspects of care of the critically ill patient with liver failure or methodology. We adh...
Woodworth, Kate R;
Moulia, Danielle;
Collins, Jennifer P;
Hadler, Stephen C;
Jones, Jefferson M;
Reddy, Sujan C;
Chamberland, Mary;
Campos-Outcalt, Doug;
Morgan, Rebecca L;
Brooks, Oliver;
Talbot, H. Keipp;
Lee, Grace M;
Bell, Beth P;
Daley, Matthew F;
Mbaeyi, Sarah;
Dooling, Kathleen;
Oliver, Sara E.
The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine is a lipid nanoparticle–formulated, nucleoside-modified mRNA vaccine encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. On August 23, 2021, the Food and Drug Administration (FDA) approved a Biologics License Applicati...
Fleming-Dutra, Katherine E;
Wallace, Megan;
Moulia, Danielle L;
Twentyman, Evelyn;
Roper, Lauren E;
Hall, Elisha;
Link-Gelles, Ruth;
Godfrey, Monica;
Woodworth, Kate R;
Anderson, Tara C;
Rubis, Amy B;
Shanley, Edwin;
Jones, Jefferson M;
Morgan, Rebecca L;
Brooks, H. Oliver;
Talbot, Keipp;
Lee, Grace M;
Bell, Beth P;
Meyer, Sarah;
Daley, Matthew;
Oliver, Sara E.
On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) amendments for the mRNA-1273 (Moderna) COVID-19 vaccine for use in children aged 6 months–5 years, administered as 2 doses (25 µg [0.25 mL] each), 4 weeks apart, and BNT162b2 (Pfizer-BioNTech) COVID-19 va...
Wallace, Megan;
Moulia, Danielle;
Blain, Amy E;
Ricketts, Erin K;
Minhaj, Faisal S;
Link-Gelles, Ruth;
Curran, Kathryn G;
Hadler, Stephen C;
!Asif, Amimah;
Godfrey, Monica;
Hall, Elisha;
Fiore, Anthony;
Meyer, Sarah;
Su, John R;
Weintraub, Eric;
Oster, Matthew E;
Shimabukuro, Tom T;
Campos-Outcalt, Doug;
Morgan, Rebecca L;
Bell, Beth P;
Brooks, Oliver;
Talbot, H. Keipp;
Lee, Grace M;
Daley, Matthew F;
Oliver, Sara E.
The mRNA-1273 (Moderna) COVID-19 vaccine is a lipid nanoparticle-encapsulated, nucleoside-modified mRNA vaccine encoding the stabilized prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. During December 2020, the vaccine was granted Emergency Use Authorization (EUA) by the Food a...
Holguin, Fernando;
Cardet, Juan Carlos;
Chung, Kian Fan;
Diver, Sarah;
Ferreira, Diogenes S;
Fitzpatrick, Anne;
Gaga, Mina;
Kellermeye, Liz;
Khurana, Sandhya;
Knight, Shandra;
McDonald, Vanessa M;
Morgan, Rebecca L;
Ortega, Victor E;
Rigau, David;
Subbarao, Padmaja;
Tonia, Thomy;
Adcock, Ian M;
Bleecker, Eugene R;
Brightling, Chris;
Boulet, Louis-Philippe;
Cabana, Michael;
Castro, Mario;
Hamerlijnck, Dominique;
Jarjour, Nizar;
Konno, Satoshi;
Shen, Huahao;
Vitary, Cathy;
Bush, Andy.
This document provides clinical recommendations for the management of severe asthma. Comprehensive evidence syntheses, including meta-analyses, were performed to summarise all available evidence relevant to the Task Force's questions. The evidence was appraised using the Grading of Recommendations, Asses...
Duijts, Liesbeth;
van Meel, Evelien R;
Moschino, Laura;
Baraldi, Eugenio;
Barnhoorn, Magda;
Bramer, Wichor M;
Bolton, Charlotte E;
Boyd, Jeanette;
Buchvald, Frederik;
del Cerro, Maria Jesus;
Colin, Andrew A;
Ersu, Refika;
Greenough, Anne;
Halvorsen, Thomas;
Gremmen, Christiaan;
Kamphuis, Juliette;
Kotecha, Sailesh;
Rooney-Otero, Kathleen;
Schulzke, Sven;
Wilson, Andrew;
Rigau, David;
Morgan, Rebecca L;
Tonia, Thomy;
Roehr, Charles C;
Pijnenburg, Marielle W.
This document provides recommendations for monitoring and treatment of children in whom bronchopulmonary dysplasia (BPD) has been established and were discharged from the hospital, or who were older than 36 weeks of postmenstrual age. The guideline was based on pre-defined Population, Intervention, Com...